Centrum Medyczne PROMED

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Psoriasis2 trials
• Crohn's disease1 trial
• Macular degeneration1 trial
• Ulcerative colitis1 trial

Phase

• Phase 35 trials

Status

• Active, not recruiting2 trials
• Completed1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Janssen Research & Development, LLC3 trials
• InDex Pharmaceuticals1 trial
• Shanghai Henlius Biotech1 trial

Running trials

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  NCT06143878· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

  NCT06095102· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting

Closed trials

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Shanghai Henlius Biotech· Source